Medtech SAS: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Medtech SAS updates on initial public offering
Medtech SAS:Says Natixis and Oddo, joint lead managers and bookrunners of the company's initial public offering, did not exercise the over-allotment option.Says this means the final sum raised in the IPO is 20,000,007 euros, represented by 740,741 new shares.
Latest Developments for Medtech SAS
Latest Key Developments in Advanced
- Vasomedical Inc approves engagement of KPMG LLP as new independent registered public accounting firm - Form 8-K
- Yamashita Medical Instruments Co Ltd to issue year-end dividend for FY 2014
- Resonance Health Ltd not to proceed with VueKlar Cardiovascular Ltd acquisition and will focus on existing IP strategy
- Share this
- Digg this